Brokerages expect Envista Holdings Co. (NYSE:NVST) to post sales of $672.01 million for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Envista’s earnings. The lowest sales estimate is $657.70 million and the highest is $691.20 million. Envista posted sales of $640.50 million in the same quarter last year, which suggests a positive year over year growth rate of 4.9%. The firm is expected to issue its next quarterly earnings results on Thursday, November 4th.
On average, analysts expect that Envista will report full year sales of $2.87 billion for the current fiscal year, with estimates ranging from $2.82 billion to $2.90 billion. For the next year, analysts anticipate that the company will report sales of $2.97 billion, with estimates ranging from $2.82 billion to $3.04 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that follow Envista.
Envista (NYSE:NVST) last announced its quarterly earnings data on Tuesday, August 3rd. The company reported $0.53 EPS for the quarter, topping the Zacks’ consensus estimate of $0.44 by $0.09. Envista had a net margin of 5.00% and a return on equity of 6.93%.
NVST has been the topic of several research analyst reports. Zacks Investment Research raised shares of Envista from a “hold” rating to a “strong-buy” rating and set a $52.00 price objective on the stock in a research report on Saturday, May 8th. TheStreet upgraded Envista from a “d+” rating to a “c” rating in a report on Thursday, May 13th. Morgan Stanley increased their target price on Envista from $42.00 to $46.00 and gave the stock an “equal weight” rating in a research note on Friday, May 7th. Credit Suisse Group boosted their price target on Envista from $49.00 to $55.00 and gave the company an “outperform” rating in a research note on Thursday, May 6th. Finally, Piper Sandler increased their price objective on Envista from $45.00 to $47.00 and gave the stock a “neutral” rating in a research report on Wednesday. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $43.67.
In related news, General Counsel Mark E. Nance sold 14,263 shares of the business’s stock in a transaction on Friday, June 11th. The stock was sold at an average price of $44.05, for a total transaction of $628,285.15. Following the sale, the general counsel now owns 34,327 shares in the company, valued at approximately $1,512,104.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Jeffrey Kappler sold 1,717 shares of Envista stock in a transaction dated Friday, July 16th. The shares were sold at an average price of $42.00, for a total value of $72,114.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,145 shares of company stock worth $1,748,590. Company insiders own 0.82% of the company’s stock.
Several institutional investors have recently bought and sold shares of NVST. Rhumbline Advisers boosted its stake in shares of Envista by 161.6% in the 2nd quarter. Rhumbline Advisers now owns 429,265 shares of the company’s stock valued at $18,549,000 after purchasing an additional 265,176 shares during the last quarter. Teacher Retirement System of Texas raised its stake in Envista by 17.5% during the second quarter. Teacher Retirement System of Texas now owns 20,976 shares of the company’s stock worth $906,000 after buying an additional 3,127 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in Envista by 9.4% in the second quarter. GSA Capital Partners LLP now owns 5,454 shares of the company’s stock valued at $236,000 after buying an additional 470 shares during the period. Artemis Investment Management LLP boosted its position in Envista by 23.4% during the second quarter. Artemis Investment Management LLP now owns 1,020,210 shares of the company’s stock valued at $44,115,000 after acquiring an additional 193,651 shares during the last quarter. Finally, New York State Common Retirement Fund grew its holdings in Envista by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 191,246 shares of the company’s stock worth $8,264,000 after acquiring an additional 9,670 shares during the period.
NYSE NVST opened at $40.75 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.02 and a quick ratio of 0.77. The stock’s fifty day moving average price is $42.82. Envista has a 1 year low of $22.47 and a 1 year high of $46.52. The company has a market capitalization of $6.55 billion, a price-to-earnings ratio of 59.93, a P/E/G ratio of 0.86 and a beta of 1.93.
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company’s Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands.
Featured Story: Cash Flow
For more information about research offerings from Zacks Investment Research, visit Zacks.com
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you consider Envista, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Envista wasn’t on the list.
While Envista currently has a “Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.